MLABMesa Laboratories, Inc.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for ~0% a year FCF growth. The price demands less than its three-year revenue growth of 4% a year, expectations look modest.
Expensive vs its own history: P/E 148.2 vs a 77.7 median over 15 quarters (+91% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What MLAB's price assumes
Mesa Laboratories, Inc. trades at 148× earnings against 37.6× for the median Scientific & Technical Instruments name, more expensive than its own group.
Trailing P/E · Scientific & Technical Instruments median 37.6 · 3.94× the median: the market pays up for this one
- Free cash flow yield
- 7.6%
Free cash flow yield · Scientific & Technical Instruments median 4.0%
- Growth the price implies
- +0.09%
Growth the price implies · The price pays for +0.09% free cash flow growth a year for a decade; the business has delivered +14% a year over the last three.
Details›
- Technology median P/E459 names
- 36.8
- Scientific & Technical Instruments median P/E18 names
- 37.6
- Free cash flow, trailing twelve months
- $53M
- Market capitalisation
- $696M
- 3-year revenue growth
- +4.4%
- 3-year free cash flow growth
- +14%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $39.30 |
| Its own P/E history, median | $66.01 |
| Its own P/E history, upper quartile | $102.22 |
| 52-week range | $67.38 – $142.52 |
| Today | $125.99 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Scientific & Technical Instruments
Ranks #11 of 12 by RyuScore